SAD
| Biological agent |
Adverse events (n) |
Infusión-related (n) |
Serum sickness |
Severity |
|---|---|---|---|---|---|
Still |
ANAKIIRA |
1 |
1 |
SIRS + adult respiratory distress |
Severe (ICU) |
Horton |
ETANERCEPT |
8 |
1 |
Mild |
|
Sjogren |
ETANERCEPT |
2 |
1 |
Moderate |
|
Behçet |
INFLIXIMAB |
10 |
10 |
Mild |
|
Behçet |
INFLIXIMAB |
12 |
1 |
Mild |
|
Behçet |
INFLIXIMAB |
7 |
3 |
Mild |
|
DM |
INFLIXIMAB |
1 |
1 |
Anaphylactic |
Moderate |
DM |
INFLIXIMAB |
1 |
1 |
Moderate |
|
Systemic sclerosis |
INFLIXIMAB |
1 |
1 |
Moderate |
|
Horton |
INFLIXIMAB |
26 |
6 |
Mild 4,moderate 2 |
|
Sarcoidosis |
INFLIXIMAB |
3 |
1 |
Moderate |
|
Sarcoidosis |
INFLIXIMAB |
80 |
13 |
Mild |
|
Sarcoidosis |
INFLIXIMAB |
1 |
1 |
Mild |
|
Still |
INFLIXIMAB |
1 |
1 |
Moderate |
|
Still |
INFLIXIMAB |
3 |
3 |
Mild |
|
Still |
INFLIXIMAB |
1 |
1 |
Severe (ICU) |
|
Wegener |
INFLIXIMAB |
1 |
1 |
Mild |
|
Sjogren |
INFLIXIMAB |
6 |
2 |
Mild |
|
Sjogren |
INFLIXIMAB |
6 |
4 |
Mild |
|
Cyioglobulinemia |
RITUXIMAB |
1 |
1 |
fever and urticaria at 7 d |
Moderate |
Cyioglobulinemia |
RITUXIMAB |
2 |
1 |
Mild |
|
Cyioglobulinemia |
RITUXIMAB |
3 |
2 |
Mild |
|
DM |
RITUXIMAB |
5 |
3 |
Mild |
|
SLE |
RITUXIMAB |
5 |
2 |
fever and urticaria in both (1-2d) |
Moderate |
SLE |
RITUXIMAB |
5 |
1 |
Moderate |
|
SLE |
RITUXIMAB |
4 |
1 |
not detailed |
Severe |
Sjögren |
RITUXIMAB |
2 |
2 |
fever and urticaria (1) |
Mild (1) |
Sjögren |
RITUXIMAB |
6 |
5 |
artromyalg, fever, purpura (3) |
Mild (2) |
Sjögren |
RITUXIMAB |
3 |
3 |
fever + purpura (1) or urticaria (1) |
Mild (1) |
Sjögren |
RITUXIMAB |
2 |
2 |
Mild (2) |
|
Sjögren |
RITUXIMAB |
2 |
2 |
Mild/moderate(2) |
|
Sjögren |
RITUXIMAB |
1 |
1 |
Mild |
|
Wegener-MPA |
RITUXIMAB |
8 |
1 |
Moderate (1) |
|
Wegener |
RITUXIMAB |
1 |
1 |
Mild |
|
TOTAL |
81 |
10 |
moderate/severe 19 |